CryoLife, Inc. (CRY)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1655 ROBERTS BOULEVARD N W KENNESAW, GA 30144

CryoLife preserves and distributes human tissues and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. Co. distributes human tissue including the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch tissue, both processed using its proprietary SynerGraft technology. Co.'s surgical sealants and hemostats include BioGlue Surgical Adhesive, BioFoam Surgical Matrix, and PerClot, an absorbable powdered hemostat. Through its subsidiary Cardiogenesis Corporation, Co. provides treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina.

Data as of 2020-08-01
Market Cap732.542 Million Shares Outstanding37.74 Million Avg 30-day Volume456.246 Thousand
P/E Ratio Dividend Yield EPS-0.12
Price/Sales3.591 Price cash flow ratio41.5 Price free cash flow ratio76.8
Book Value7.33 Price to Tangible Book-11.93 Alpha0.01
Short Interest Ratio6.16 % Short Interest to Float10.1 R-squared0.173583
BETA0.922771 52-week High/Low31.77 / 12.63 Stddev0.095293
View SEC Filings from CRY instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 1 (0.07%)
13F Filers holding this stock: 126 28 (1.83%)
Aggregate 13F shares on 03/31/2020: 30.945 Million 10.715 Million
Aggregate 13F shares on 12/31/2019: 29.327 Million 10.034 Million
Percent change: 5.52% 6.79%
Funds creating new positions: 21 6
Funds Adding to an existing position: 45 12
Funds closing out their position: 25 8
Funds reducing their position: 34 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BARTHOLD FRANZ PETER VP, RESEARCH & DEVELOPMENT

  • Officer
6,934 2020-07-01 1

MORGAN HARVEY

  • Director
92,687 2020-06-01 3

MCCALL RONALD D

  • Director
133,433 2020-06-01 5

BEVEVINO DANIEL J

  • Director
115,437 2020-06-01 2

ACKERMAN THOMAS F

  • Director
115,272 2020-06-01 2

SALVESON JON W

  • Director
95,216 2020-06-01 2

BULLOCK JAMES

  • Director
24,023 2020-06-01 2

BURBANK JEFFREY H

  • Director
19,172 2020-06-01 2

BORGSTROM MARNA P

  • Director
14,464 2020-06-01 2

HORTON AMY VP, CHIEF ACCOUNTING OFFICER

  • Officer
99,642 2020-05-28 6

LEE DAVID ASHLEY EXECUTIVE VP, COO & CFO

  • Officer
289,067 2020-05-22 6

CAPPS SCOTT B VP, CLINICAL RESEARCH

  • Officer
0 2020-05-05 6

MACKIN JAMES P PRESIDENT & CEO

  • Officer
0 2020-05-05 6

HOLLOWAY JEAN F VP, GENERAL COUNSEL

  • Officer
0 2020-05-05 9

DAVIS JOHN E SENIOR VP, GLOBAL SALES

  • Officer
0 2020-05-05 5

MAIER DENNIS B VICE PRESIDENT, OPERATIONS

  • Officer
0 2020-05-05 5

BOGENSCHUETZ THOMAS J VP, EMEA & GENERAL MANAGER

  • Officer
0 2020-05-05 3

SIMPSON MICHAEL S SVP, REGULATORY AFFAIRS AND QA

  • Officer
0 2020-05-05 4

GETZ MATTHEW A VP, HUMAN RESOURCES

  • Officer
0 2020-05-05 2

SAURINI SHERRY M VP, QUALITY

  • Officer
25,084 2019-03-14 0

MCDERMID JAMES M SVP, CHRO

  • Officer
30,806 2019-03-14 0

RONALD C ELKINS

  • Director
64,843 2018-09-05 0

MATTHEWS WILLIAM ROBERT SENIOR VP, OPERATIONS, QUALITY

  • Officer
39,883 2018-03-05 0

GALE DAVID C VP, RESEARCH & DEVELOPMENT

  • Officer
77,135 2017-11-16 0

BENSON JAMES

  • Director
54,086 2017-10-02 0

ANDERSON STEVEN G FORMER EXECUTIVE CHAIRMAN

  • Officer
No longer subject to file 2015-04-09 0

FRONK DAVID VP, REGULATORY AFFAIRS

  • Officer
110,559 2015-03-07 0

ANDERSON BRUCE G. VP, US SALES &GLOBAL MARKETING

  • Officer
104,096 2015-03-07 0

LANG DAVID P. VP, INT'L SALES & MARKETING

  • Officer
73,441 2015-02-26 0

BURRIS JEFFREY W VICE PRESIDENT & GEN. COUNSEL

  • Officer
95,221 2014-08-15 0

SEERY GERALD B SR. VP, SALES AND MARKETING

  • Officer
71,999 2012-11-30 0

HEACOX ALBERT E SR. VP RESEARCH AND DEVL

  • Officer
No longer subject to file 2011-12-31 0

COOK JOHN M

  • Director
104,500 2009-06-09 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments